menu
    • menu

    Company profile for CureVac

    NEW Drugs in Dev: 25
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We fight for human health – the RNA people. We are performing the pioneering research in developing a completely new class of medicine based on the molecule messenger RNA (mRNA). The principle of our technology is the use of this molecule as a data carrier to instruct the human body to produce its own proteins capable of fighting a wide range of diseases. We are headquartered in Tübingen, Germany, and have sites in Frankfu...
    We fight for human health – the RNA people. We are performing the pioneering research in developing a completely new class of medicine based on the molecule messenger RNA (mRNA). The principle of our technology is the use of this molecule as a data carrier to instruct the human body to produce its own proteins capable of fighting a wide range of diseases. We are headquartered in Tübingen, Germany, and have sites in Frankfurt, Germany, and Boston, Massachusetts, USA. Because of our leading technology, we have received investments from SAP founder Dietmar Hopp’s dievini and from the Bill & Melinda Gates Foundation.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CureVacGermany Flag
    Country
    Country
    Germany
    Address
    Address
    Paul-Ehrlich-Str. 15, 72076 Tübingen
    Telephone
    Telephone
    +49 7071 9883 - 0
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.curevac.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/curevac/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/CureVacAG

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    BioNTech Closes CureVac Acquisition, Bolstering mRNA Position
    BioNTech Closes CureVac Acquisition, Bolstering mRNA Position

    18 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/18/3207494/0/en/BioNTech-Closes-Acquisition-of-CureVac-N-V-Including-Subsequent-Offering-Period-to-Strengthen-its-Unique-Position-in-the-mRNA-Field.html

    GLOBENEWSWIRE
    18 Dec 2025
    Share Share
    BioNTech Achieves Minimum Condition In Curevac Exchange Offer
    BioNTech Achieves Minimum Condition In Curevac Exchange Offer

    03 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/03/3198964/0/en/BioNTech-Achieves-Minimum-Condition-in-CureVac-Exchange-Offer.html

    GLOBENEWSWIRE
    03 Dec 2025
    Share Share
    BioNTech Sets Dec. 3, 2025 Deadline for CureVac Shares
    BioNTech Sets Dec. 3, 2025 Deadline for CureVac Shares

    26 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/26/3195060/0/en/BioNTech-Shares-Progress-on-Exchange-Offer-for-CureVac-Shares-and-Highlights-December-3-2025-at-9-00-a-m-Eastern-Time-Expiration.html

    GLOBENEWSWIRE
    26 Nov 2025
    Share Share
    Curevac Announces Voting Results Of Extraordinary General Meeting
    Curevac Announces Voting Results Of Extraordinary General Meeting

    25 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-25/curevac-announces-voting-results-of-extraordinary-general-meeting

    PHARMIWEB
    25 Nov 2025
    Share Share
    Curevac Reveals Q3 & 9-Month 2025 Financials, Business Updates
    Curevac Reveals Q3 & 9-Month 2025 Financials, Business Updates

    24 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-24/curevac-announces-financial-results-for-the-third-quarter-and-first-nine-months-of-2025-and-provides

    PHARMIWEB
    24 Nov 2025
    Share Share
    Biontech Starts Public Exchange Offer For Curevac Shares
    Biontech Starts Public Exchange Offer For Curevac Shares

    22 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/22/3170919/0/en/BioNTech-Commences-Public-Exchange-Offer-for-All-Outstanding-Shares-of-CureVac-N-V.html

    GLOBENEWSWIRE
    22 Oct 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search